OmniAb, Inc. has grown revenue −17% a year over three years and −14% a year over five. Revenue growth, 3-year annual rate: −17% (Biotechnology median +17%). Revenue growth, 5-year rate: −14%, growth has slowed since the five-year average. Years of annual history on file: 5, FY2021 to FY2025, as filed.

OABIOmniAb, Inc.

Healthcare

$2.51+47% 1Y

$2.51

$1.3652 weeks$5.03

Is it growing?

Good

Growing: revenue growing +67% year on year and operating margin widening (+97.1 points).

2 good, 1 without data

Revenue trend+67% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+97.1 points operating

Trailing-twelve-month operating margin, -275.5% now against -372.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is OABI growing?

OmniAb, Inc. has grown revenue −17% a year over three years and −14% a year over five.

−17%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −14%
Revenue growth, 5-year rate · −17% over three · growth has slowed since the five-year average
Years of annual history on file: 5
Years of annual history on file · FY2021 to FY2025, as filed

Details›